ACLU, PubPat Seek Supreme Court Review of Myriad Lawsuit | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The American Civil Liberties Union and the Public Patent Foundation have petitioned the US Supreme Court to hear their case against Myriad Genetics, which seeks to invalidate patents on the BRCA1 and BRCA2 genes that are licensed by Myriad.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: new chromatin imaging approach, and more.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.